We serve Chemical Name:1-(1,3-benzodioxol-5-yl)-2,5-dimethylpyrrole-3-carbaldehyde CAS:409353-81-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(1,3-benzodioxol-5-yl)-2,5-dimethylpyrrole-3-carbaldehyde
CAS.NO:409353-81-7
Synonyms:1-(1,3-benzodioxol-5-yl)-2,5-dimethylpyrrole-3-carbaldehyde
Molecular Formula:C14H13NO3
Molecular Weight:243.25800
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:399.2ºC at 760 mmHg
Density:1.26g/cm3
Index of Refraction:1.611
PSA:40.46000
Exact Mass:243.09000
LogP:2.63530
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(1,3-benzodioxol-5-yl)-2,5-dimethylpyrrole-3-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(1,3-benzodioxol-5-yl)-2,5-dimethylpyrrole-3-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(1,3-benzodioxol-5-yl)-2,5-dimethylpyrrole-3-carbaldehyde Use and application,1-(1,3-benzodioxol-5-yl)-2,5-dimethylpyrrole-3-carbaldehyde technical grade,usp/ep/jp grade.
Related News: Over the duration of this study, investigators observed a 4.2% reduction in annualised absolute risk of cardiovascular death or heart failure hospitalisations compared to placebo. 2-oxothiazolidine-4-carboxylic acid 1-ethoxycarbonyl phenylmethyl ester manufacturers Ultimately, AZ hopes to shape the market by working with Chinese authorities to develop guidance on how rare disease drugs can be included for national coverage at reasonable prices, Wang said. methyl 3-(N-((S)-1-amino-1-oxo-3-phenylpropan-2-yl)-N-((6S,7aS)-2-(4-butoxyphenyl)-1,3-dioxohexahydro-1H-pyrrolo[1,2-c]imidazol-6-yl)sulfamoyl)thiophene-2-carboxylate suppliers Patients having Zynteglo treatment for beta thalassaemia also need conditioning treatment to clear out their bone marrow cells before receiving Zynteglo. Healthcare professionals should therefore explicitly inform patients receiving Zynteglo of the increased risk of blood cancers from medicines used in conditioning treatments. 3-Azidopropanoic acid vendor & factory.
